<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901320/" ref="ordinalpos=4502&amp;ncbi_uid=2332500&amp;link_uid=PMC2901320" image-link="/pmc/articles/PMC2901320/figure/F5/" class="imagepopup">Figure 5.  From: Expression of a retinoic acid signature in circulating CD34 cells from coronary artery disease patients. </a></div><br /><div class="p4l_captionBody"><b>The CXCR4 pathway is affected in CD34+ cells from CAD patients</b>. Genes with a lower expression in CD34+ cells from CAD patients represent the Chemotaxis CXCR4 signaling pathway (P = 2.1 Ã— 10-3). Genes expressed at significantly lower levels are indicated by a red arrow and are encircled for clarity.</div></div>